Wegovy is intended for use in adults with obesity (body mass index [BMI] of 30 kg/m or greater) or overweight individuals (BMI of 27 kg/m or greater) with at least one weight-related comorbidity, such as type 2 diabetes or high blood pressure
Similarly, ebselen also showed synergistic effects with silver, making it more selective for pathogenic bacteria than for mammalian cells (Zou et al., 2017)
This is the same mechanism that causes vaginal atrophy during menopause, but in the context of semaglutide, it happens faster because the weight loss occurs over months rather than years
Yao H, Zhang A, Li D, Wu Y, Wang C-Z, Wan J-Y, et al
Peptides 31 , 22892293 (2010) Zhang, H